2.6 C
New York
Friday, February 26, 2021

Brazil trials of Sinovac COVID-19 vaccine show promising results: governor

Must read

imageCoronavirus13 minutes ago (Sep 09, 2020 04:30PM ET)

2/2

(C) Reuters. FILE PHOTO: Outbreak of the coronavirus disease (COVID-19), in Sao Paulo

2/2

SAO PAULO (Reuters) – The governor of Brazil’s Sao Paulo state said on Wednesday that Phase 3 clinical trials of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd have shown promising results and it may be available to Brazilians as early as December.

Governor Joao Doria added that Phase 2 trials of the potential vaccine had shown an immune response of 98% in the elderly.

Some 9,000 Brazilian volunteers are participating in the Sinovac vaccine trials, which are being conducted by the Butantan Institute in Sao Paulo city and 11 other locations, including the capital, Brasilia.

Brazil, which has the third worst outbreak of the novel coronavirus in the world after the United States and India, has become a testing ground for at least two vaccine candidates.

One such vaccine is being developed by AstraZeneca (NYSE:AZN), which has had to pause global trials after an unexplained illness in a participant in Britain.

Trials for the AstraZeneca vaccine on 5,000 volunteers in Brazil are well advanced and have not produced any problems in participants, according to the immunobiology center of Sao Paulo’s Federal University, which is running the trials.

Vaccination of volunteers in Sao Paulo, Rio de Janeiro and Salvador have been put on hold, but work continues monitoring those who have received the first and even the second dose, a university representative said.

At the start of next year, Phase 3 trials of Russia’s “Sputnik-V” COVID-19 vaccine will also be conducted on 10,000 volunteers in Brazil in partnership with the state of Parana’s Technology Institute, known as Tecpar

Brazilian lab and hospital group DASA SA said on Wednesday it had agreed to conduct Phase 2 and 3 trials in Brazil for a COVID-19 vaccine developed by COVAXX, a unit of privately owned United Biomedical Inc.

On Tuesday, Brazil’s acting Health Minister Eduardo Pazuello said a COVID-19 vaccine would be rolled out for all Brazilians in a mass vaccination starting in January.

Brazil trials of Sinovac COVID-19 vaccine show promising results: governor

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

- Advertisement -

Latest article